Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression

Archives of General Psychiatry

Volumn 66, Issue 3, 2009, Pages 324-330

  Kumar, Anand ^a,c   Gupta, Rakesh ^b   Thomas, Albert ^a   Ajilore, Olusola ^a   Hellemann, Gerhard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIPIZIDE; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORPUS CALLOSUM; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FRONTAL LOBE; GRAY MATTER; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PATHOPHYSIOLOGY; STRUCTURED INTERVIEW; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; WHITE MATTER;

EID: 61449087416     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2008.548     Document Type: Article

References (58)

1. Harati Y, Diabetes and the nervous system, Endocrinol Metab Clin North Am. 1996;25(2):325-359.
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol. 2006;5(1):64-74.
3. Gavard JA, Lustman PJ, Clouse RE, Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care. 1993;16(8):1167-1178,
4. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes: a prospective population-based study. Diabetes Care. 1996; 19(10):1097-1102.
5. Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among US adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008;31(1):105-107.
6. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000; 160(21):3278-3285.
7. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B. Relationship of depression and diabetes selfcare, medication adherence, and preventive care. Diabetes Care. 2004;27(9): 2154-2160.
8. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications. 2005;19(2):113-122.
9. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, Young B, Von Korff M. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668-2672.
10. Fuster JM. The prefrontal cortex: an update: time is of the essence. Neuron. 2001; 30(2):319-333.
11. Kumar A, Cook IA. White matter injury, neural connectivity and the pathophysiology of psychiatric disorders. Dev Neurosci. 2002;24(4):255-261.
12. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993; 50(8):873-880.
13. Cummings JL. The neuroanatomy of depression. J Clin Psychiatry. 1993;54(suppl):14-20.
14. Alexopoulos GS. Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr Psychiatry. 2002;10(6):687-695.
15. Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007;10(9):1116-1124.
16. Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J, Miller J, Thomas MA, Kumar A. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology. 2007;32(6):1224-1231.
17. Kumar A, Haroon E, Darwin C, Pham D, Ajilore O, Rodriguez G, Mintz J. Gray matter prefrontal changes in type 2 diabetes detected using MRI. J Magn Reson Imaging. 2008;27(1):14-19.
18. Soininen H, Puranen M, Helkala EL, Laakso M, Riekkinen PJ. Diabetes mellitus and brain atrophy: a computed tomography study in an elderly population. Neurobiol Aging. 1992;13(6):717-721.
19. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler MM. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia. 2003;46(12):1604-1610.
20. Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial ( J-EDIT). Diabetes Metab Res Rev. 2006;22(5):376-384.
21. Eng J, Ceckler TL, Balaban RS. Quantitative 1H magnetization transfer imaging in vivo. Magn Reson Med. 1991;17(2):304-314.
22. Balaban RS, Ceckler TL. Magnetization transfer contrast in magnetic resonance imaging. Magn Reson Q. 1992;8(2):116-137.
23. Kumar A, Gupta RC, Albert TM, Alger J, Wyckoff N, Hwang S. Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer. Psychiatry Res. 2004;130(2): 131-140.
24. Ballmaier M, Kumar A, Elderkin-Thompson V, Narr KL, Luders E, Thompson PM, Hojatkashani C, Pham D, Heinz A, Toga AW. Mapping callosal morphology in early- and late-onset elderly depression: an index of distinct changes in cortical connectivity [published online ahead of print August 22, 2007]. Neuropsychopharmacology. 2008;33(7):1528-1536.
25. Ballmaier M, Sowell ER, Thompson PM, Kumar A, Narr KL, Lavretsky H, Welcome SE, DeLuca H, Toga AW. Mapping brain size and cortical gray matter changes in elderly depression. Biol Psychiatry. 2004;55(4):382-389.
26. Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Fam Physician. 1998;58(6):1355-1370.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
28. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
29. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-198.
30. American Heart Association. Stroke Risk Factor Prediction Chart. Dallas, TX: American Heart Association; 1990.
31. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622-626.
32. Watari K, Letamendi A, Elderkin-Thompson V, Haroon E, Miller J, Darwin C, Kumar A. Cognitive function in adults with type 2 diabetes and major depression. Arch Clin Neuropsychol. 2006;21(8):787-796.
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc B. 1995;57:289-300.
34. Tukey JW. Components in regression. Biometrics. 1951;7(1):33-69.
35. Selemon LD, Goldman-Rakic PS. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci. 1985;5(3):776-794.
36. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986; 9:357-381.
37. Chow TW, Cummings JL. Frontal-subcortical circuits. In: Miller BL, Cummings JL, eds. The Human Frontal Lobes. New York, NY: The Guilford Press; 1999:3-26.
38. Roberts AC, Tomic DL, Parkinson CH, Roeling TA, Cutter DJ, Robbins TW, Everitt BJ. Forebrain connectivity of the prefrontal cortex in the marmoset monkey (Callithrix jacchus): an anterograde and retrograde tract-tracing study. J Comp Neurol. 2007;502(1):86-112.
39. Taylor WD, Steffens DC, McQuoid DR, Payne ME, Lee SH, Lai TJ, Krishnan KR. Smaller orbital frontal cortex volumes associated with functional disability in depressed elders. Biol Psychiatry. 2003;53(2):144-149.
40. Ballmaier M, Narr KL, Toga AW, Elderkin-Thompson V, Thompson PM, Hamilton L, Haroon E, Pham D, Heinz A, Kumar A. Hippocampal morphology and distinguishing late-onset from early-onset elderly depression.Am J Psychiatry. 2008; 165(2):229-237.
41. Alexander MP, Naeser MA, Palumbo CL. Correlations of subcortical CT lesion sites and aphasia profiles. Brain. 1987;110(pt 4):961-991.
42. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12(10):366-375.
43. Starkstein SE, Robinson RG, Berthier ML, Parikh RM, Price TR. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol. 1988;45 (7):725-730.
44. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol. 2008;7(3):246-255.
45. Weintraub D, Hurtig HI. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. Am J Psychiatry. 2007;164(10): 1491-1498.
46. Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol. 1994;36 (suppl):S97-S99.
47. Bjartmar C, Yin X, Trapp BD. Axonal pathology in myelin disorders. J Neurocytol. 1999;28(4-5):383-395.
48. Foong J, Symms MR, Barker GJ, Maier M, Woermann FG, Miller DH, Ron MA. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain. 2001;124(pt 5):882-892.
49. Kumar R, Gupta RK, Rathore RK, Rao SB, Chawla S, Pradhan S. Multiparametric quantitation of the perilesional region in patients with healed or healing solitary cysticercus granuloma. Neuroimage. 2002;15(4):1015-1020.
50. Chen JT, Kuhlmann T, Jansen GH, Collins DL, Atkins HL, Freedman MS, O'Connor PW, Arnold DL; Canadian MS/BMT Study Group. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. Neuroimage. 2007;36(4):1152-1158.
51. Bruno SD, Barker GJ, Cercignani M, Symms M, Ron MA. A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry [published online ahead of print October 6, 2004]. Brain. 2004;127(pt 11):2433-2440.
52. Hanyu H, Asano T, Sakurai H, Takasaki M, Shindo H, Abe K. Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease. J Neurol Sci. 2001;188(1-2):79-84.
53. Gunning-Dixon FM, Hoptman MJ, Lim KO, Murphy CF, Klimstra S, Latoussakis V, Majcher-Tascio M, Hrabe J, Ardekani BA, Alexopoulos GS. Macromolecular white matter abnormalities in geriatric depression: a magnetization transfer imaging study. Am J Geriatr Psychiatry. 2008;16(4):255-262.
54. Hanyu H, Shimizu S, Tanaka Y, Kanetaka H, Iwamoto T, Abe K. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease. Neurosci Lett. 2005;380(1-2):166-169.
55. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, Lycklama à Nijeholt GJ, van der Valk P, Polman CH, Thompson AJ, Barkhof F. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999;46(5):747-754.
56. Schmierer K, Tozer DJ, Scaravilli F, Altmann DR, Barker GJ, Tofts PS, Miller DH. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging. 2007;26(1):41-51.
57. Hickman SJ, Toosy AT, Jones SJ, Altmann DR, Miszkiel KA, MacManus DG, Barker GJ, Plant GT, Thompson AJ, Miller DH. Serial magnetization transfer imaging in acute optic neuritis. Brain. 2004;127(pt 3):692-700.
58. Emmer BJ, Steens SC, Steup-Beekman GM, van der Grond J, Admiraal-Behloul F, Olofsen H, Bosma GP, Ouwendijk WJ, Huizinga TW, van Buchem MA. Detection of change in CNS involvement in neuropsychiatric SLE: a magnetization transfer study. J Magn Reson Imaging. 2006;24(4):812-816.